0001123292-16-001556.txt : 20160113
0001123292-16-001556.hdr.sgml : 20160113
20160113170548
ACCESSION NUMBER: 0001123292-16-001556
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160111
FILED AS OF DATE: 20160113
DATE AS OF CHANGE: 20160113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Fred E
CENTRAL INDEX KEY: 0001339358
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 161341270
MAIL ADDRESS:
STREET 1: 301 COMMERCE STREET
STREET 2: SUITE 3300
CITY: FORT WORTH
STATE: TX
ZIP: 76102
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2016-01-11
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001339358
Cohen Fred E
C/O FIVE PRIME THERAPEUTICS, INC.
TWO CORPORATE DRIVE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2016-01-11
4
M
0
4065
8.49
A
4177
D
Common Stock
2016-01-11
4
M
0
4065
5.54
A
8242
D
Common Stock
2016-01-11
4
M
0
4065
7.26
A
12307
D
Common Stock
2016-01-11
4
M
0
12500
12.70
A
24807
D
Stock Option (right to buy)
8.49
2016-01-11
4
M
0
4065
0
D
2021-07-13
Common Stock
4065
0
D
Stock Option (right to buy)
5.54
2016-01-11
4
M
0
4065
0
D
2022-07-10
Common Stock
4065
0
D
Stock Option (right to buy)
7.26
2016-01-11
4
M
0
4065
0
D
2023-07-18
Common Stock
4065
0
D
Stock Option (right to buy)
12.70
2016-01-11
4
M
0
12500
0
D
2024-05-15
Common Stock
12500
0
D
This option is fully vested and immediately exercisable.
/s/ Francis Sarena, Attorney-in-Fact
2016-01-13